06609.HK
Shanghai HeartCare Medical Technology Corporation Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 53.20
+0.47%Year over year
Reported trailing growth
- Revenue
- +53.4%
- EBITDA
- +361.6%
- EBIT
- +109.9%
- EPS
- +125.5%
- Free cash flow
- +219.4%
- Operating cash flow
- +153.6%
Forward estimates
Based on analyst estimates
- Revenue
- -13.7%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +30.7%
- EBITDA
- +231.8%
- EBIT
- +810.2%
- Net income
- +711.8%
- EPS
- +713.9%
- Free cash flow
- +1768.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026